FDA Issues Emergency Use Authorization for Drug to Treat New World Screwworm in Dogs and Puppies
Food and Drug Administration today issued an Emergency Use Authorization (EUA) for Simparica TRIO (sarolaner, moxidectin, and pyrantel chewable tablets) for the treatment of New World screwworm (NWS) infestations (myiasis) in dogs and puppies. Currently, most dogs in the U.S.
Reported by 2 outlets — FDA, The Hill. See all sources ↓
Food and Drug Administration today issued an Emergency Use Authorization (EUA) for Simparica TRIO (sarolaner, moxidectin, and pyrantel chewable tablets) for the treatment of New World screwworm (NWS) infestations (myiasis) in dogs and puppies. Currently, most dogs in the U.S. are at low risk of NWS exposure due to their geographic location. However, dogs that live in, travel to, or return from areas where NWS infestations have been identified by state or federal animal health officials, as well as certain countries south of the U.S.
Why it matters
2 outlets are covering this world story — one to watch as reporting develops.
- What's the story?
- Food and Drug Administration today issued an Emergency Use Authorization (EUA) for Simparica TRIO (sarolaner, moxidectin, and pyrantel chewable tablets) for the treatment of New World screwworm (NWS) infestations (myiasis) in dogs and puppies. Currently, most dogs in the U.S.
- How widely is it covered?
- 2 outlets, average source rating 8.5/10.
- When was it last updated?
- 4m ago.
How outlets are framing the same story
Here's how each outlet is covering the story — compare their headlines and timing at a glance.
- Coverage card2 outlets1CoverageScouting report
FDA Issues Emergency Use Authorization for Drug to Treat New World Screwworm in Dogs and Puppies
Sources2TypeCoverageFDA
The Hill